Biotage AB (publ) (BITGF)
USD 14.8
(0.0%)
USD 14.8
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 22.41 Million USD | -3.03% |
| 2022 | 23.11 Million USD | -16.04% |
| 2021 | 27.52 Million USD | 5.49% |
| 2020 | 26.09 Million USD | 44.63% |
| 2019 | 18.04 Million USD | 46.2% |
| 2018 | 12.33 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 150 Million USD | 505.09% |
| 2024 Q2 | 41.31 Million USD | -32.67% |
| 2024 Q1 | 61.36 Million USD | -0.84% |
| 2023 FY | 61.88 Million USD | 167.77% |
| 2023 Q3 | 37.2 Million USD | 4.98% |
| 2023 Q2 | 35.44 Million USD | 60.69% |
| 2023 Q4 | 61.88 Million USD | 66.31% |
| 2023 Q1 | 22.05 Million USD | -4.56% |
| 2022 Q2 | 23.86 Million USD | 13.48% |
| 2022 FY | 23.11 Million USD | -16.04% |
| 2022 Q4 | 23.11 Million USD | 3.06% |
| 2022 Q3 | 22.42 Million USD | -6.03% |
| 2022 Q1 | 21.02 Million USD | -23.61% |
| 2021 Q1 | 26.67 Million USD | 0.0% |
| 2021 Q4 | 27.52 Million USD | 108.51% |
| 2021 Q3 | 13.2 Million USD | -3.89% |
| 2021 Q2 | 13.73 Million USD | -48.51% |
| 2021 FY | 27.52 Million USD | 5.49% |
| 2020 FY | 26.09 Million USD | 44.63% |
| 2019 FY | 18.04 Million USD | 46.2% |
| 2018 FY | 12.33 Million USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -4382.313% |
| Ansell Limited | 855.59 Million USD | 97.381% |
| Ansell Limited | 857.2 Million USD | 97.385% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -106953.083% |
| Psykey, Inc. | 1.01 Million USD | -2117.649% |
| ConvaTec Group Plc | 1.31 Billion USD | 98.29% |
| ConvaTec Group Plc | 1.31 Billion USD | 98.292% |
| Encision Inc. | 1.33 Million USD | -1581.033% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -870.737% |
| Innovative MedTech Inc. | 1.87 Million USD | -1093.231% |
| LifePoint, Inc. | 446.74 Thousand USD | -4916.69% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -315.477% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -923.827% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -9136.397% |
| SmileDirectClub, Inc. | 871.79 Million USD | 97.429% |
| Sector 10, Inc. | 164 Thousand USD | -13565.587% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 96.675% |
| SheerVision, Inc. | 75 Thousand USD | -29782.084% |
| United Health Products, Inc. | 755.98 Thousand USD | -2864.536% |
| Vasamed, Inc. | 23.45 Thousand USD | -95471.697% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -709.851% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -2735.116% |